Garheng Kong

CIK 1435183 · last filed 2026-06-05

Garheng Kong is a corporate insider who has filed 77 SEC Form 4 insider transactions across 10 companies since 2012. The most recent filing, for XERS, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$4.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $57.5M across reported positions. 26 SEC filings were submitted jointly with LABORATORY CORP OF AMERICA HOLDINGS.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$57.48M
Companies
10
Total Filings
77
Lifetime Open-Market Net
-$4.58M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

CSTL price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
712 COLLEGE AVENUE
MENLO PARK, CA 94025
Related Filers
LABORATORY CORP OF AMERICA HOLDINGS — 26 joint filings, latest 2026-02-13
Sofinnova HealthQuest Partners, L.P. — 10 joint filings, latest 2020-05-19
HealthQuest Venture Management, L.L.C. — 9 joint filings, latest 2020-05-19
American Oncology Network, Inc. — 1 joint filings, latest 2023-11-09
James Healy — 1 joint filings, latest 2012-10-04
Michael Powell — 1 joint filings, latest 2012-10-04
Sofinnova Management VIII, L.L.C. — 1 joint filings, latest 2012-10-04
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count in each company: direct shares plus every indirect holder (trusts, LLCs, partnerships, family members) on the latest Form 4 that lists them. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
XERS Director 238,337 $16.61 $3.96M $0 7 2026-06-05
LH Director 13,739 $369.85 $5.08M $0 24 2026-02-13
Venus Concept Inc. (VERO) Delisted Director 41,186 $0.31 $12.8K $2.00M 8 2023-03-28
ALIMERA SCIENCES INC (ALIM) Delisted Director — $5.54 — $0 12 2023-01-06
Strongbridge Biopharma plc (SBBP) Delisted Director 0 $2.00 $0 $0 8 2021-10-06
CSTL 10%+ Owner 1,433,577 $33.79 $48.44M -$8.62M 1 2020-05-14
AVEDRO INC (AVDR) Delisted Director 0 $24.25 $0 $2.00M 3 2019-11-26
Venus Concept Inc. (HAIR) Delisted Director 266,375 — — $0 1 2019-11-07
MELINTA THERAPEUTICS, INC. /NEW/ (MLNT) Delisted Director — — — $0 1 2018-06-14
MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted Director 2,830 — — $49.3K 7 2017-01-05

Holdings By Holder

Who holds the shares on record: the insider directly, and each trust, LLC, partnership or family member reported as an indirect holder on the latest Form 4 that lists them. Holder names come from the filing's footnotes. Rows under No longer reported appeared on earlier filings but not the latest one, usually because the holder was emptied or folded into another; they are not counted in the total.
Symbol Holder Shares Share of Total Reported
VERO Held by HealthQuest Partners II, L.P. 41,186 100.0% 2021-12-17
Total 41,186
No longer reported
HealthQuest Partners II, L.P.
By Partnership
31,489 — last 2020-06-18
AVDR HealthQuest Partners II, L.P.
See footnote
0 — 2019-11-26
Total 0
HAIR HealthQuest Partners II, L.P.
By Partnership
266,375 100.0% 2019-11-07
Total 266,375

Recent Filings

77 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144, so not all of them end in a sale. Under each notice: the role the filer ticked on it, and whether a sale followed (a Form 4 sale within 30 days, or a sale listed on a later notice).
Filed Symbol Action Net Shares Net $ Link
2026-06-05 XERS Grant (A) +24,193 $0 EDGAR
2026-02-13 LH Exer (M) +897 $0 EDGAR
2026-02-12 LH Grant (A) — $0 EDGAR
2025-06-04 XERS Grant (A) +50,000 $0 EDGAR
2025-02-13 LH Grant (A) — $0 EDGAR
2025-02-10 LH Exer (M) +944 $0 EDGAR
2024-06-05 XERS Grant (A) +50,000 $0 EDGAR
2024-04-01 XERS Other (J) +6,474 $0 EDGAR
2024-02-08 LH Mixed +947 $0 EDGAR
2023-06-07 XERS Grant (A) +42,500 $0 EDGAR
Showing 1–10 of 77
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).